Establishing Newborn Screening for SCID in the USA; Experience in California

Area of Science:

• Immunology
• Pediatrics
• Genetics

Background:

• Severe combined immunodeficiency (SCID) poses a significant risk of fatal infections in newborns.
• Early diagnosis and intervention are critical for managing SCID and improving infant outcomes.
• T-cell receptor excision circles (TRECs) are byproducts of normal T-lymphocyte development.

Purpose of the Study:

• To evaluate the effectiveness of newborn screening for SCID.
• To assess the utility of TREC analysis in identifying infants with T-lymphocyte defects.
• To demonstrate the impact of a large-scale SCID newborn screening program.

Main Methods:

• Screening DNA from infant dried blood spots.
• Quantification of T-cell receptor excision circles (TRECs) as a biomarker.
• Analysis of data from over 3 million screened infants in California.

Main Results:

• TREC screening reliably identifies infants with SCID and other T-lymphocyte deficiencies.
• The California SCID newborn screening program has demonstrated significant effectiveness.
• Prompt diagnosis through screening prevents life-threatening infectious complications.

Conclusions:

• Newborn screening for SCID using TREC analysis is a highly effective public health measure.
• Early detection enables timely treatment, drastically improving survival rates for infants with SCID.
• Large-scale implementation of SCID screening programs is crucial for pediatric health.